MedicineWatch US
Class II Recall

McKesson

Product
Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL single-dose vial, Rx only, Mfd by: CELLTRION, INC, Dist. by: Pfizer Labs, Division of Pfizer Inc., New York, NY 10001, NDC 0069-0809-01
Reason
cGMP Deviations: Product intended for quarantine was inadvertently distributed.
Classification
Class II
Status
Ongoing
Lot
Lot# 04647349, Exp Date 5/31/2029
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.